Literature DB >> 20568110

CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells.

Min Wang, Juan Xiao, Jianxin Jiang, Renyi Qin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20568110     DOI: 10.1002/ijc.25519

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.

Authors:  Richard E Kast; Alex Alfieri; Hazem I Assi; Terry C Burns; Ashraf M Elyamany; Maria Gonzalez-Cao; Georg Karpel-Massler; Christine Marosi; Michael E Salacz; Iacopo Sardi; Pieter Van Vlierberghe; Mohamed S Zaghloul; Marc-Eric Halatsch
Journal:  Cancers (Basel)       Date:  2022-05-23       Impact factor: 6.575

2.  Osteosarcoma: mouse models, cell of origin and cancer stem cell.

Authors:  Maria V Guijarro
Journal:  Postdoc J       Date:  2014-02

3.  Sarcoma stem cells: do we know what we are looking for?

Authors:  Matteo Trucco; David Loeb
Journal:  Sarcoma       Date:  2012-05-09

Review 4.  Increased Oxidative Stress as a Selective Anticancer Therapy.

Authors:  Jiahui Liu; Zhichong Wang
Journal:  Oxid Med Cell Longev       Date:  2015-07-26       Impact factor: 6.543

Review 5.  Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Simone Brivio; Carlo Spirli; Ruth E Joplin; Mario Strazzabosco; Luca Fabris
Journal:  Int J Mol Sci       Date:  2017-01-13       Impact factor: 5.923

6.  A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.

Authors:  Matteo M Trucco; Christian F Meyer; Katherine A Thornton; Preeti Shah; Allen R Chen; Breelyn A Wilky; Maria A Carrera-Haro; Lillian C Boyer; Margaret F Ferreira; Umber Shafique; Jonathan D Powell; David M Loeb
Journal:  Clin Sarcoma Res       Date:  2018-11-05

7.  Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.

Authors:  F Peng; J Jiang; Y Yu; R Tian; X Guo; X Li; M Shen; M Xu; F Zhu; C Shi; J Hu; M Wang; R Qin
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.